[Clinical research in private sector: Which strategic analysis?].
Fiche publication
Date publication
août 2023
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GUIHARD Sébastien
Tous les auteurs :
Ruffier A, Pointreau Y, Sacier V, Balavoine M, Lamrani-Ghaouti A, Guihard S, Rivera S
Lien Pubmed
Résumé
Clinical research in private practice has significantly increased in recent years and has become crucial for the attractiveness of centres both for patients who can access innovative treatments and molecules and for participating physicians. The responsiveness, the size and reduced number of interlocutors, flexibility, and decision-making autonomy of private practitioners are strengths in the strategic analysis of clinical research in the private sector. However, the varied medical activity allowing for broader recruitment, location of practice, and administrative time related leadership roles can become weakness in terms of quality and time dedicated to this research activity, which still relies heavily on strong individual involvement. Collaborations, which develop when clinical research in private centres is dynamic, are sources of opportunities, growth, and progress, allowing participation in various ambitious projects that can benefit patients in these facilities. Recent administrative and legislative complexities for trial integration and competition with academic structures can threaten this important clinical research activity for private practices, requiring reflection on its valorisation and promotion to ensure its sustainability.
Mots clés
Analyse stratégique, Clinical research, Clinical trials, Essais thérapeutiques, Libéral, Private institute, Recherche clinique, SWOT analysis
Référence
Cancer Radiother. 2023 08 16;: